JPM JPMORGAN CHASE & CO Insider Trading

General Counsel Stacey Friedman sells 5,467 JPM shares at $330.73 under 10b5-1 plan

Stacey Friedman, General Counsel of JPMorgan Chase, sold 5,467 shares on 2026-06-22 at $330.73, reducing holdings by -11.8% from 46,428 to 40,961 shares. This transaction is part of a pre-arranged 10b5-1 trading plan and therefore executed on a scheduled basis rather than in discretionary response to market conditions. Across her five prior JPM trades, same-ticker outcomes have been mixed: the most recent prior sale on 2026-05-20 saw a 30-day return of +8.3%, while sales in early 2026 posted modest negative 30-day returns of -6.0% and -3.3%, suggesting no consistent pattern of timing execution relative to this security's price movements. JPMorgan remains well-capitalized with a market cap of $888.2B, net income of $16.5B in the latest quarter, and a P/E of 15.08.

General Counsel Friedman Stacey sold 5,468 shares of JPM at $300.27; scheduled 10b5-1 execution, holdings now 46,428 shares.

Friedman Stacey, General Counsel of JPMorgan Chase, sold 5,468 shares on 2026-05-20 at $300.27 under a pre-arranged 10b5-1 trading plan, reducing holdings from 51,896 to 46,428 shares. The transaction is scheduled and non-discretionary, not a signal of insider discretion. JPMorgan trades at a P/E of 13.74 with recent quarterly net income of $16.5B on $49.8B revenue, reflecting solid fundamental performance. The insider's cross-ticker track record shows an average 90-day return of +2.5% following 11 prior sells, while same-ticker history at JPM across 5 prior trades shows mixed 90-day outcomes: +9.7%, -0.9%, -1.8%, +3.1%, and -4.8%.

CEO Mary E. Erdoes sells 6,648 JPM shares at $298.36 for $1,983,526.53 under 10b5-1 plan.

Mary E. Erdoes, CEO of Asset & Wealth Management, executed a sale of 6,648 shares for $1,983,526.53 on 2026-05-15, reducing her JPM holdings from 639,047 to 632,399 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, indicating it was scheduled rather than a discretionary decision made in response to current market conditions. JPM trades at $297.81 currently, 11.7% below its 52-week high of $337.25 and down 2.6% over 30 days, while the company shows solid fundamentals with $49.8B quarterly revenue, $16.5B in net income, and a P/E of 13.55. The sale is routine executive portfolio management of a substantial position held by a top-tier executive.

CEO Lake Marianne of JPMorgan Chase sold 6,427 shares at $298.36 for $1.9M on 2026-05-15 under 10b5-1 plan

Lake Marianne, CEO of JPMorgan Chase, executed a scheduled sale of 6,427 shares for $1.9M under a pre-arranged 10b5-1 trading plan, reducing her holdings from 82,829 shares to 76,402 shares. The sale occurred while JPM traded at $297.81, down 11.7% from its 52-week high of $337.25 and down 2.6% over the prior 30 days. Because this transaction is part of a 10b5-1 plan, it reflects a predetermined schedule rather than a discretionary trading decision, limiting what can be inferred about her current market view. JPMorgan Chase reported $49.8B in quarterly revenue, $16.5B in net income, and trades at a P/E of 13.55 with a $798.0B market cap, indicating the company remains operationally sound despite recent price weakness.

Co-CEO Douglas B Petno sold 5,659 shares at $300.05 on 2026-05-15 via 10b5-1 plan; holding remains 135,027 shares.

Petno executed a scheduled 10b5-1 trading plan sale of 5,659 shares for $1,697,982.95, reducing holdings from 140,686 to 135,027 shares. The filing includes three transaction line items, though only the 5,659-share lot at $300.05 on 2026-05-15 represented a cash sale; the other two entries (135,027 shares each at $0.00) appear to be non-cash or netting adjustments. Since this transaction is part of a pre-arranged 10b5-1 trading plan, it reflects scheduled execution rather than discretionary decision-making. Petno's broader insider transaction history at JPM shows 5 prior sales over the past year, with 4 of 5 having negative 90-day post-sale returns, indicating his sales at this ticker have historically coincided with subsequent declines. The stock is currently trading at $297.81, approximately 11.7% below its 52-week high of $337.25, and has declined 2.6% over the past 30 days.

CIO Beer sells 3,165 JPM shares at $300.05; 10b5-1 plan. Holdings: 66.8K post-transaction.

Beer Lori A, Chief Information Officer, sold 3,165 shares of JPMORGAN CHASE & CO (JPM) at $300.05 on 2026-05-15 under a pre-arranged 10b5-1 trading plan, reducing her holdings to 66,783 shares. The sale was scheduled, not discretionary. JPM trades at a P/E of 13.55 with latest quarterly revenue of $49,836,000,000.00 and net income of $16,494,000,000.00, representing annual revenue growth of +2.8%. The total transaction value was $949,658.25.

JPMorgan CFO Jeremy Barnum sells ~$935K in stock, disposing roughly 8.5% of holdings near recent lows.

Jeremy Barnum, JPMorgan's Chief Financial Officer, sold approximately 3,000 shares in early May, trimming roughly 8.5% of his holdings. The sale came at a time when JPMorgan stock was trading noticeably below its highs from earlier in the year, having recently recovered from a shallow pullback. Given Barnum's role managing the company's finances and capital allocation, the modest size of this sale—less than a million dollars—and the partial nature of the disposition suggest routine portfolio rebalancing rather than a vote of no confidence. JPMorgan itself remains a solidly profitable financial institution with growing revenue and reasonable valuation, providing little fundamental reason for alarm. This filing is primarily routine: CFO transactions of this scale occur regularly and lack the pattern or conviction signal that would mark a meaningful insider move.

JPMorgan Chief Risk Officer Ashley Bacon sells $1.26M in shares; stock trading below recent highs, company fundamentally sound.

Ashley Bacon, the Chief Risk Officer at JPMorgan Chase, sold a meaningful block of shares worth approximately $1.26 million—reducing his stake by a small portion of his holdings. While the sale crosses a reporting threshold, it represents less than two percent of Bacon's position, suggesting deliberate portfolio rebalancing or liquidity needs rather than a wholesale loss of confidence. The timing is noteworthy: JPMorgan's stock is currently trading below its recent highs after a modest recovery over the past month, and the sale occurred as the company continues to demonstrate solid profitability with stable revenue growth. Bacon's role as Chief Risk Officer—someone with direct visibility into the bank's operational health and risk exposure—makes even routine sales worth noting, though this particular transaction lacks the urgency or conviction signal that would come from a much larger reduction or from multiple officers selling simultaneously.

JPM Co-CEO Petno sold 5,660 shares at $306.58 on 2026-04-15; prior JPM sales mixed on timing, current price $305.93

Douglas B Petno, Co-CEO of CIB, sold 5,660 shares at $306.58, reducing JPM holdings from 387,467 to 381,807 shares (a -1.5% reduction). At his cross-ticker historical rate, Petno's prior sells showed 28.57% well-timed outcomes with an average 90-day return of +5.0%, but his same-ticker history at JPM is mixed: of 3 prior sales with measurable 90-day outcomes, 2 were well-timed (negative returns after sale), 1 was poorly timed. JPM's current price of $305.93 is -8.6% from the 52-week high and +6.9% over the past 30 days, while fundamentals remain stable at a P/E of 14.58 with $46.4B quarterly revenue and $14.4B net income. The transaction reflects a modest portfolio adjustment by a senior executive against a backdrop of near-recent-peak valuations.

Dimon sells 130.5K JPM shares at $306.56; holds 1.68M post-sale amid strong quarterly earnings

James Dimon sold 130,488 shares for $40,002,009.82 on 2026-04-15, reducing his holdings from 1,811,113 to 1,680,625 shares (a -7.2% reduction). His cross-ticker track record shows 20 prior sales with a 90-day well-timed rate of 50.00%, though at JPM specifically, his 5 prior trades (all sold 2026-02-19) posted -6.7% 30-day returns with no measurable 90-day outcomes yet. The sale occurred near the stock's 52-week high of $334.61 (current price $305.93 is -8.6% below peak) and follows a +6.9% 30-day rally. JPM's fundamentals remain robust with $46.4B quarterly revenue, $14.4B net income, and a 14.58 P/E ratio. The execution appears discretionary rather than formula-driven, warranting examination of whether this reflects portfolio rebalancing or forward-looking positioning by the bank's chief executive.